These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 6149133

  • 1. Remoxipride, a new potential antipsychotic compound with selective antidopaminergic actions in the rat brain.
    Ogren SO, Hall H, Köhler C, Magnusson O, Lindbom LO, Angeby K, Florvall L.
    Eur J Pharmacol; 1984 Jul 20; 102(3-4):459-74. PubMed ID: 6149133
    [Abstract] [Full Text] [Related]

  • 2. The selective dopamine D2 receptor antagonist raclopride discriminates between dopamine-mediated motor functions.
    Ogren SO, Hall H, Köhler C, Magnusson O, Sjöstrand SE.
    Psychopharmacology (Berl); 1986 Jul 20; 90(3):287-94. PubMed ID: 2947255
    [Abstract] [Full Text] [Related]

  • 3. [Selective antidopaminergic properties of remoxiprid, a new potential antipsychotic agent].
    Ogren SO, Hall H, Köhler C, Magnusson O, Florvall L.
    Arzneimittelforschung; 1985 Jul 20; 35(8):1227-31. PubMed ID: 2866774
    [Abstract] [Full Text] [Related]

  • 4. Studies on the mechanism of action of substituted benzamide drugs.
    Köhler C, Ogren SO, Fuxe K.
    Acta Psychiatr Scand Suppl; 1984 Jul 20; 311():125-37. PubMed ID: 6142588
    [Abstract] [Full Text] [Related]

  • 5. Neuropharmacological and behavioural properties of remoxipride in the rat.
    Ogren SO, Florvall L, Hall H, Magnusson O, Angeby-Möller K.
    Acta Psychiatr Scand Suppl; 1990 Jul 20; 358():21-6. PubMed ID: 1978483
    [Abstract] [Full Text] [Related]

  • 6. Biochemical pharmacology of the atypical neuroleptic remoxipride.
    Köhler C, Hall H, Magnusson O, Lewander T, Gustafsson K.
    Acta Psychiatr Scand Suppl; 1990 Jul 20; 358():27-36. PubMed ID: 1978484
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
    Köhler C, Haglund L, Ogren SO, Angeby T.
    J Neural Transm; 1981 Jul 20; 52(3):163-73. PubMed ID: 7198139
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Regional displacement by sulpiride of [3H]spiperone binding in vivo. Biochemical and behavioural evidence for a preferential action of limbic and nigral dopamine receptors.
    Köhler C, Ogren SO, Haglund L, Angeby T.
    Neurosci Lett; 1979 Jun 20; 13(1):51-6. PubMed ID: 572522
    [Abstract] [Full Text] [Related]

  • 12. Potential antipsychotic agents. 7. Synthesis and antidopaminergic properties of the atypical highly potent (S)-5-bromo-2,3-dimethoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl]benzamide and related compounds. A comparative study.
    Högberg T, de Paulis T, Johansson L, Kumar Y, Hall H, Ogren SO.
    J Med Chem; 1990 Aug 20; 33(8):2305-9. PubMed ID: 1973734
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
    Magnusson O, Mohringe B, Thorell G, Lake-Bakaar DM.
    Pharmacol Toxicol; 1987 May 20; 60(5):368-73. PubMed ID: 2886989
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
    Magnusson O, Mohringe B, Fowler CJ.
    J Neural Transm; 1987 May 20; 69(3-4):163-77. PubMed ID: 2957465
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 20; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.